Clinical and morphologic features of hypertrophic cardiomyopathy in elderly patients 85 years or older

Z Y Lai1, C M Shih, N C Chang

  • 1Department of Medicine, Taipei Medical College and Hospital, Taiwan.

Insights

Elderly patients with hypertrophic cardiomyopathy (HC) exhibit unique left ventricular (LV) morphology, characterized by basal septal bulging and anterior hypertrophy. Advanced age and mild hypertension appear to influence this distinctive geometry in older individuals.

Area of Science:

  • Cardiology
  • Geriatrics
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HC) is a complex cardiac condition.
  • Distinctive left ventricular (LV) morphology in elderly patients with HC requires further investigation.
  • The influence of advanced age and hypertension on HC morphology is not fully understood.

Purpose of the Study:

  • To investigate the unique left ventricular (LV) morphology in elderly patients (>= 85 years) with hypertrophic cardiomyopathy (HC).
  • To explore the relationship between advanced age, mild hypertension, and the characteristic LV geometry in this population.

Main Methods:

  • Comparative study of 14 elderly HC patients (>= 85 years) and 45 young HC patients (<= 40 years).
  • Clinical data collection including age, hypertension status, and syncope occurrence.
  • Echocardiographic assessment of LV wall thickness, septal bulging, and hypertrophy patterns.

Main Results:

  • Elderly patients presented with milder LV wall thickening (18 +/- 4 mm vs 25 +/- 8 mm) compared to younger patients.
  • A significantly higher prevalence of basal septal bulging (86% vs 0%) and anterior septal hypertrophy (79% vs 0%) was observed in the elderly group.
  • Mild hypertension was prevalent in 71% of elderly patients and correlated with basal septal bulging and anterior septal hypertrophy.

Conclusions:

  • Elderly patients (>= 85 years) with HC display a striking and distinct left ventricular (LV) morphology.
  • Advanced age and mild hypertension are likely contributing factors to the unique geometry observed in elderly HC patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...